TARDBP突变所致肌萎缩侧索硬化:从遗传学到TDP-43蛋白病
TARDBP突变仅占家族性肌萎缩侧索硬化的3-5%、散发性不到1%,但TDP-43神经元包涵体是多数病例的神经病理标志。突变多位于TDP-43蛋白C端,病理条件下TDP-43从细胞核错误定位至细胞质,发生磷酸化、剪切并形成不溶性聚集,导致RNA代谢等下游通路功能障碍。针对TDP-43功能障碍的生物标志物与靶向治疗正在开发中。
要点
- TARDBP突变占家族性ALS的3-5%、散发性ALS不到1%。
- TDP-43神经元包涵体是多数ALS病例的神经病理标志。
- 突变多位于TDP-43蛋白C端,可致表型异质性。
核心结论
- TDP-43从细胞核错误定位至细胞质并形成不溶性聚集,导致RNA代谢等下游通路功能障碍,是TARDBP突变相关ALS的核心病理机制。
研究设计与样本
- 综述,围绕TARDBP突变所致ALS从遗传学到TDP-43蛋白病的机制与转化研究进行汇总。
主要发现
- TARDBP突变占家族性ALS的3-5%,占表观散发性ALS不到1%。
- 多数TARDBP突变位于TDP-43蛋白C端,单个突变可引起表型异质性。
- 病理条件下TDP-43从细胞核错误定位至细胞质,可被磷酸化、剪切并形成不溶性聚集。
- TDP-43错误定位导致RNA代谢、蛋白稳态、线粒体功能、氧化应激、轴突运输和局部翻译等下游通路功能障碍。
关键数值与推荐
- TARDBP突变占家族性ALS病例的3-5%。
- TARDBP突变占表观特发性ALS病例不到1%。
- 多数突变位于TDP-43蛋白C端。
临床怎么用
- TDP-43功能障碍的生物标志物与靶向治疗正在开发中,原文对个性化医学方法持谨慎乐观态度。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mutations in the TARDBP gene, which encodes the TDP-43 protein, account for only 3-5% of familial cases of amyotrophic lateral sclerosis and less than 1% of cases that are apparently idiopathic. However, the discovery of neuronal inclusions of TDP-43 as the neuropathological hallmark in the majority of cases of amyotrophic lateral sclerosis has transformed our understanding of the pathomechanisms underlying neurodegeneration. An individual TARDBP mutation can cause phenotypic heterogeneity. Most mutations lie within the C-terminus of the TDP-43 protein. In pathological conditions, TDP-43 is mislocalised from the nucleus to the cytoplasm, where it can be phosphorylated, cleaved, and form insoluble aggregates. This mislocalisation leads to dysfunction of downstream pathways of RNA metabolism, proteostasis, mitochondrial function, oxidative stress, axonal transport, and local translation. Biomarkers for TDP-43 dysfunction and targeted therapies are being developed, justifying cautious optimism for personalised medicine approaches that could rescue the downstream effects of TDP-43 pathology.
引用
- Balendra R, Sreedharan J, Hallegger M, et al. Amyotrophic lateral sclerosis caused by TARDBP mutations: from genetics to TDP-43 proteinopathy. Lancet Neurol. 2025. PMID: 40252666. doi:10.1016/S1474-4422(25)00109-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。